INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
British Pharmaceutical Industry advocates 'light speed' drug development using digital and AI

British Pharmaceutical Industry advocates 'light speed' drug development using digital and AI

People are going to suffer harm, even death, if this is not stopped

Hedley Rees's avatar
Hedley Rees
Nov 09, 2023
∙ Paid
15

Share this post

INSIDE PHARMA
INSIDE PHARMA
British Pharmaceutical Industry advocates 'light speed' drug development using digital and AI
9
2
Share

Share

Association of the British Pharmaceutical Industry

Subscribers may remember this post from a few days ago:

ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY'S NARRATIVE SENDS CHILLS UP YOUR SPINE

Hedley Rees
·
November 7, 2023
ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY'S NARRATIVE SENDS CHILLS UP YOUR SPINE

INSIDE PHARMA is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. November 2023 edition of the Pharma Times Please take a minute or two to read the editorial introduction, ‘Familiar foe’ from the November 2023 edition of the

Read full story

As you may know, PharmaTimes Magazine is the ABPIs monthly publication. I began taking my free copy over twenty years ago. Can’t be bothered to cancel it, so I just drop it in the bin/trash every month. This month, for some strange reason, a masochistic urge came over me, and I read the introduction by the editor, John Pinching.

I voted this comment below highest on the chillometer scale:

“Navigating threats at light speed will continue to dictate the narrative, with technology, digital, AI and life sciences taking a leading role…more specifically, doctors and nurses will inevitably embrace ‘the future’ and collaborate with it.”

I’m sure it won’t need translating for you critical thinking subscribers here, but I will add another post from some time ago that you may have forgotten.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share